Foghorn Jumps on the News of Partnership With Lilly for Novel Oncology Medicines
(Lilly) Shares of Foghorn Therapeutics Inc. rose more than 47% on Monday on the news that Eli Lilly and Company has selected its Gene Traffic Control platform for novel oncology…